Clot Management Devices Market Size (2024 - 2029)

The clot management devices market is experiencing growth driven by an increased demand for thrombosis management, particularly due to the heightened risk of cardiovascular diseases during the COVID-19 pandemic. The rising geriatric population, which is a significant risk factor for deep vein thrombosis, along with the growing preference for minimally invasive surgeries and technological advancements, are key contributors to the market's expansion. Despite challenges such as stringent regulatory processes and the availability of alternative treatments, the market is benefiting from product innovations and launches, which are expected to further propel its growth.

Home Market Analysis Healthcare Research Medical Devices Research Clot Management Devices Market Market Size

Market Size of Clot Management Devices Industry

Clot Management Devices Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.85 Billion
Market Size (2029) USD 2.48 Billion
CAGR (2024 - 2029) 6.04 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Clot Management Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Clot Management Devices Market Analysis

The Clot Management Devices Market size is estimated at USD 1.85 billion in 2024, and is expected to reach USD 2.48 billion by 2029, growing at a CAGR of 6.04% during the forecast period (2024-2029).

The COVID-19 pandemic had a significant impact on the market studied. The risk of cardiovascular diseases increased during the pandemic and increased the risk of thrombosis (blood clotting) among the target patients. This increased the demand for the devices used for thrombosis management. According to the article "Cardiovascular Disease Management in COVID 19" published in April 2022, blood coagulation (clot) issues have been linked to COVID-19 infection globally.

In addition, another article, "Risks of Deep Vein Thrombosis, Pulmonary Embolism, and Bleeding After COVID-19: Nationwide Self-Controlled Cases Series and Matched Cohort Study," published in April 2022, stated that deep vein thrombosis increased during the pandemic, and it was higher during the initial phase of the pandemic in Sweden. Thus, for the management of thrombosis, the demand for clot management devices increased. This fuelled the studied market growth.

Factors such as the rise in cardiovascular diseases coupled with the increasing geriatric population, growing demand for minimally invasive surgeries, and technological advancements contribute to market growth. The rising geriatric population across the world is creating various disease burdens. This leads to increasing surgeries and blood clots among the target population.

The World Health Organization (WHO) estimates that by 2050, there will be 2.1 billion people worldwide who are 60 years of age or older, up from 1 billion in 2020. In addition, several sources and research show that the population aged 60 years or more is the foremost independent risk factor for deep vein thrombosis (when blood clot forms in one or more of the deep veins in the body). Thus, the increasing geriatric population coupled with the burden of thrombosis among them is expected to create demand for clot management devices, thereby driving the market growth over the analysis period.

Additionally, the global market for clot management devices has increased in recent years in product innovation, approval, and launches. For instance, in November 2021, Precision Medical Products (PMP) released the newest iteration of its Circul8 Pro device, a powerful and portable take-home deep vein thrombosis (DVT) prevention product. With 20-plus-hour battery life, the Circul8 Pro is one of the market's longest-lasting portables, battery-operated compression devices. Thus, such advances in the market are predicted to drive the studied market growth globally. Thus, the studied market is expanding with innovation and launches.

However, the stringent regulatory process and availability of alternative treatments are expected to restrain the market's growth.

Clot Management Devices Industry Segmentation

As per the scope of the report, the formation of a thrombus in a blood vessel is known as thrombosis (blood clotting). This stops blood circulation in an artery or vein. Clot management devices help to remove or dissolve blood clots and restore blood circulation. 

The clot management devices market is segmented by by product (embolectomy balloon catheter, catheter directed thrombolysis devices, percutaneous thrombectomy devices, inferior vena cava filters, and neurovascular embolectomy devices), end-user (hospitals, ambulatory surgical centers and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Product
Embolectomy Balloon Catheter
Catheter Directed Thrombolysis Devices
Percutaneous Thrombectomy Devices
Inferior Vena cava Filters
Neurovascular Embolectomy Devices
By End-User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Clot Management Devices Market Size Summary

The clot management devices market is poised for steady growth, driven by an increasing prevalence of cardiovascular diseases and a rising geriatric population. The demand for these devices has been further amplified by the COVID-19 pandemic, which highlighted the risks of thrombosis among infected individuals. This surge in demand is supported by technological advancements and the growing preference for minimally invasive surgeries. The market is characterized by continuous product innovation, with new devices and improvements in existing ones enhancing their efficacy and usability. However, the market's expansion is tempered by stringent regulatory processes and the availability of alternative treatments, which pose challenges to market growth.

North America is expected to lead the market, with the United States at the forefront due to its high healthcare expenditure and the increasing prevalence of cardiovascular conditions. The aging population in the region, coupled with the rise in coronary artery diseases, is driving the demand for clot management devices. The market is moderately competitive, with key players focusing on product innovations and regional expansions to capture a larger market share. Recent product launches and approvals in North America are further propelling market growth, as companies continue to introduce advanced solutions for effective thrombosis management.

Explore More

Clot Management Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population

      2. 1.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Procedures

      2. 1.3.2 Availability of Alternative Treatments

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value in USD million)

    1. 2.1 By Product

      1. 2.1.1 Embolectomy Balloon Catheter

      2. 2.1.2 Catheter Directed Thrombolysis Devices

      3. 2.1.3 Percutaneous Thrombectomy Devices

      4. 2.1.4 Inferior Vena cava Filters

      5. 2.1.5 Neurovascular Embolectomy Devices

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Ambulatory Surgical Centers

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Clot Management Devices Market Size FAQs

The Clot Management Devices Market size is expected to reach USD 1.85 billion in 2024 and grow at a CAGR of 6.04% to reach USD 2.48 billion by 2029.

In 2024, the Clot Management Devices Market size is expected to reach USD 1.85 billion.

Clot Management Devices Market Report Snapshots

Clot Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)